慢性リンパ球性白血病(CLL)：世界の臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Lymphocytic Leukemia (CLL) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chronic Lymphocytic Leukemia (CLL) 25
Subjects Recruited Over a Period of Time 35
Clinical Trials by Sponsor Type 36
Prominent Sponsors 37
Top Companies Participating in Chronic Lymphocytic Leukemia (CLL) Therapeutics Clinical Trials 38
Prominent Drugs 40
Latest Clinical Trials News on Chronic Lymphocytic Leukemia (CLL) 41
Jan 07, 2014: Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis 41
Dec 10, 2013: MorphoSys Announces Additional Clinical Trial of MOR208 42
Dec 10, 2013: Emergent BioSolutions’ Otlertuzumab (TRU-016) Shows Positive Results in Combination with Rituximab in People with CLL 42
Dec 08, 2013: Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia and T-Cell Lymphoma at ASH Annual Meeting 43
Dec 07, 2013: Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 45
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
F. Hoffmann-La Roche Ltd. 46
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46
Celgene Corporation 52
Clinical Trial Overview of Celgene Corporation 52
GlaxoSmithKline plc 57
Clinical Trial Overview of GlaxoSmithKline plc 57
Pharmacyclics, Inc. 61
Clinical Trial Overview of Pharmacyclics, Inc. 61
Sanofi 64
Clinical Trial Overview of Sanofi 64
Bayer AG 66
Clinical Trial Overview of Bayer AG 66
Gilead Sciences, Inc. 68
Clinical Trial Overview of Gilead Sciences, Inc. 68
Johnson & Johnson 70
Clinical Trial Overview of Johnson & Johnson 70
AbbVie Inc. 72
Clinical Trial Overview of AbbVie Inc. 72
Clinical Trial Overview of Top Institutes / Government 74
National Cancer Institute 74
Clinical Trial Overview of National Cancer Institute 74
The University of Texas M. D. Anderson Cancer Center 83
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 83
Fred Hutchinson Cancer Research Center 87
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 87
Memorial Sloan Kettering Cancer Center 90
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 90
National Heart, Lung, and Blood Institute 92
Clinical Trial Overview of National Heart, Lung, and Blood Institute 92
Mayo Clinic 93
Clinical Trial Overview of Mayo Clinic 93
Masonic Cancer Center 94
Clinical Trial Overview of Masonic Cancer Center 94
University of California, San Diego 95
Clinical Trial Overview of University of California, San Diego 95
Eastern Cooperative Oncology Group 96
Clinical Trial Overview of Eastern Cooperative Oncology Group 96
Five Key Clinical Profiles 97
Appendix 196
Abbreviations 196
Definitions 196
Research Methodology 197
Secondary Research 197
About GlobalData 198
Contact Us 198
Disclaimer 198
Source 199